Free tool
Dividend paying stocks
We cover 100 companies that currently pay a dividend. The median market value in the group is $6.84B. Across the group, the median move over the past trading day is 0.00%. 71% of the 99 with a 200-day average trade above it. Price change over the past year runs from −21.8% to +65.3% across the middle 80 percent of the group, with a median of +8.1%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
100 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.12T | Mega cap | +68.40% |
| LLY | Eli Lilly and Company | $1.10T | Mega cap | +78.28% |
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +69.06% |
| JNJ.DE | Johnson & Johnson | $659.04B | Mega cap | +54.31% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +56.92% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +48.73% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +29.69% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +31.10% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +23.44% |
| MRCK34.SA | Merck & Co., Inc. | $384.82B | Mega cap | +77.08% |
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| RHO.DE | Roche Holding AG | $377.17B | Mega cap | +39.70% |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% |
| NOT.DE | NOVARTIS AG N | $303.40B | Mega cap | +27.82% |
| N1VS34.SA | Novartis AG | $303.05B | Mega cap | +20.51% |
| NVS | Novartis AG | $300.35B | Mega cap | +31.84% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% |
| AZN.ST | AstraZeneca PLC | $263.97B | Mega cap | +2.47% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | $260.90B | Mega cap | +1.51% |
| AMG.DE | Amgen Inc. | $241.28B | Mega cap | +56.55% |
| AMGN34.SA | Amgen Inc. | $239.24B | Mega cap | +47.86% |
| AMGN | Amgen Inc. | $239.09B | Mega cap | +56.64% |
| TMO | Thermo Fisher Scientific Inc. | $232.26B | Mega cap | +28.46% |
| TN8.DE | Thermo Fisher Scientific Inc. | $231.85B | Mega cap | +27.50% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.50B | Mega cap | +22.09% |
| NVO | Novo Nordisk A/S | $215.18B | Mega cap | −10.46% |
| NOV.DE | Novo Nordisk A/S | $213.87B | Mega cap | +11.69% |
| NOVO-B.CO | Novo Nordisk A/S | $212.57B | Mega cap | −13.21% |
| N1VO34.SA | Novo Nordisk A/S | $210.56B | Mega cap | −17.65% |
| NVO.WA | NVONORDSK | $210.19B | Mega cap | −11.47% |
| ABT | Abbott Laboratories | $202.28B | Mega cap | −10.54% |
| ABTT34.SA | Abbott Laboratories | $201.07B | Mega cap | −15.33% |
| ABL.DE | Abbott Laboratories | $200.83B | Mega cap | −9.70% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −21.76% |
| KRK.WA | Krka, d. d. | $9.12B | Mid cap | +31.52% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| 4523.T | Eisai Co., Ltd. | $8.67B | Mid cap | +9.74% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +3.09% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% |
| 2413.T | M3, Inc. | $7.39B | Mid cap | −20.12% |
| RHC.AX | Ramsay Health Care Limited | $7.33B | Mid cap | +18.74% |
| ALK-B.CO | ALK-Abelló A/S | $7.23B | Mid cap | +8.24% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +21.56% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | $6.65B | Mid cap | +12.04% |
| HLUN-B.CO | H. Lundbeck A/S | $6.61B | Mid cap | +5.61% |
| HLUN-A.CO | H. Lundbeck A/S | $6.55B | Mid cap | +26.06% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.17% |
| COH.AX | Cochlear Limited | $6.38B | Mid cap | −53.16% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| CTEC.L | Convatec Group PLC | $6.06B | Mid cap | −2.30% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −19.07% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| 000100.KS | Yuhan Corporation | $4.67B | Mid cap | −25.59% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.63B | Mid cap | −11.37% |
| OBCK.DE | Ottobock SE & Co. KGaA I | $4.51B | Mid cap | −0.82% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.47B | Mid cap | +80.49% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +22.31% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.04B | Mid cap | −0.90% |
| MCOV-B.ST | Medicover AB (publ) | $3.91B | Mid cap | −10.12% |
| 000105.KS | Yuhan Corporation | $3.88B | Mid cap | −31.05% |
| FIE.DE | Fielmann Group AG | $3.85B | Mid cap | −30.39% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.80B | Mid cap | +22.85% |
| 7459.T | MediPal Holdings Corporation | $3.77B | Mid cap | +14.74% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.27B | Mid cap | −27.10% |
| AFX.DE | Carl Zeiss Meditec AG | $3.26B | Mid cap | −23.23% |
| BIOA-B.ST | BioArctic AB (publ) | $3.24B | Mid cap | +20.03% |
| VIRP.PA | Virbac SA | $3.22B | Mid cap | −2.81% |
| AMBU-B.CO | Ambu A/S | $3.20B | Mid cap | −19.61% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.19B | Mid cap | −28.33% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.03B | Mid cap | −22.60% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.08% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.00% |
| EBO.AX | EBOS Group Limited | $2.72B | Mid cap | −35.38% |
| 2784.T | Alfresa Holdings Corporation | $2.57B | Mid cap | +7.97% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +6.99% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.44B | Mid cap | +63.50% |
| DMP.DE | Dermapharm Holding SE | $2.43B | Mid cap | +14.86% |
| EKTA-B.ST | Elekta AB (publ) | $2.27B | Mid cap | +19.21% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.26B | Mid cap | +10.13% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +147.28% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −11.16% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| GNS.L | Genus plc | $2.08B | Mid cap | −13.32% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +78.59% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.